secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEXGEL, INC. (NXGL)
CIK:        0001468929
Form:       8-K
Filed at:   2021-09-15T23:59:59+00:00
Accession:  0001104659-21-115812
Event type: leadership
Sentiment:  positive
Materiality: 0.35
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NEXGEL appoints three directors, grants options to purchase 1.5M shares at $0.15 each
--------------------------------------------------------------------------------

- Yaakov Spinrad, Miranda Toledano, and CEO Adam Levy appointed to Board.
- Each appointee received a non-qualified option for 500,000 shares at $0.15, vesting in four quarterly installments starting Oct 1, 2021.
- Toledano expected to chair future Audit Committee; eligible for $10,000 quarterly retainer upon national exchange listing.
- Toledano brings over 20 years biopharma and capital markets experience, including roles at TRIGR, Sorrento, and Royalty Pharma.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468929/000110465921115812/0001104659-21-115812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468929/000110465921115812/tm2127717d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-115812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer